Acurx Pharmaceuticals Financial Overview
Acurx Pharmaceuticals's market cap is currently $10.03M. The company's EPS TTM is $-1.23; its P/E ratio is -0.45; Acurx Pharmaceuticals is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-1.01. See an overview of income statement, balance sheet, and cash flow financials.
